Achromobacter spp. healthcare associated infections in the French West Indies: a longitudinal study from 2006 to 2016

• Published in: BMC infectious diseases Vol. 19; no. 1; p. 795
• Main Authors: Marion-Sanchez, Karine, Pailla, Karine, Olive, Claude, Le Coutour, Xavier, Derancourt, Christian
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 10.09.2019; BioMed Central; BMC
• Subjects: Achromobacter; Achromobacter spp., healthcare associated infection; Antibiotics; Bacteremia; Bacteria; Care and treatment; Correlation analysis; Cross infection; Cystic fibrosis; Epidemics; Fibrosis; Health care; High resistance; Immune status; Immunocompetence; Immunocompetent; Incidence; Infection; Infections; Longitudinal studies; Microbial drug resistance; Multidrug resistance; Nosocomial infections; Patients; Pneumonia; Proteobacteria; Reservoirs (Water); Resistance, retrospective study; Risk factors; Strains (organisms); Caribbean Islands; West Indies; Achromobacter spp., healthcare associated infection; Immunocompetent; Resistance, retrospective study
• ISSN: 1471-2334; 1471-2334
• DOI: 10.1186/s12879-019-4431-3

Bacteria of the Achromobacter genus, more particularly xylosoxidans species, are responsible for various healthcare associated infections (HAI) which are increasingly described since the last decade. Cystic fibrosis (CF) patients are considered as potential reservoirs in hospitals. We performed a retrospective study to estimate the frequencies of Achromobacter spp. HAI among patients from French West Indies, to determine characteristics of infected patients and establish a possible link between CF and infections. All adults with at least one Achromobacter spp. positive sample and infection criteria in accordance with European official definitions of HAI, hospitalized in University Hospital of Martinique from 2006 to 2016 for more than 48 h, were included. Patient clinical features, immune status and underlying diseases were obtained from medical files. A list of CF patients was given by clinicians. Antibiotic-susceptibility profiles of the strains were determined using an automated method. Mean incidence density was 0.038/1000 days of hospitalization. Achromobacter spp. HAI evolved as an endemic situation with a low but pretty much stable incidence rate over the 11-year observation period. An epidemic peak was noticed in 2013. Among the 66 included patients, 56.1% were immunocompetent and no one had CF. Pneumonia and bacteraemia were the two main HAI. Among the 79 isolated strains, 92.4% were resistant to at least 1 major antibiotic and 16.4% met the definition of multidrug-resistant bacteria. This microorganism, little known in our country because of the scarcity of CF patients, represents a threat for both immunosuppressed and immunocompetent patients and a therapeutic challenge because of its high resistance.